Regulatory Post-Marketing Surveillance (PMS) Study for AVAXIM 160U (Hepatitis A Vaccine)

Trial Profile

Regulatory Post-Marketing Surveillance (PMS) Study for AVAXIM 160U (Hepatitis A Vaccine)

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Jul 2016

At a glance

  • Drugs Hepatitis A vaccine inactivated (Primary) ; Hepatitis A vaccine inactivated (Primary)
  • Indications Hepatitis A
  • Focus Adverse reactions
  • Sponsors sanofi pasteur
  • Most Recent Events

    • 25 Jul 2016 Status changed from active, no longer recruiting to completed.
    • 09 Oct 2015 Planned End Date changed from 1 Nov 2015 to 1 May 2016 as reported by ClinicalTrials.gov record.
    • 09 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top